Oakwood Medical Investors is a St. Louis, Missouri based venture capital firm. They invest in the life sciences industry, and focus on companies in the development stage medical device, biopharmaceutical and healthcare service sectors.
Oakwood Medical Investors has made investments in EndoGastric Solutions, Sadra Medical, Mitralign, EKOS Corporation, OptiScan Biomedical, Adiana, Quick Study Radiology, Insulet, MedVantx, Insulet, TransMolecular, Achillion Pharmaceuticals and Atairgin Technologies.
They have exited their investments in Achillion Pharmaceuticals, Sadra Medical, Insulet, EKOS Corporation, Adiana and TransMolecular.
EndoGastric Solutions is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD).
Daniel A. Burkhardt
James L. Nouss
Jason A. Darrah
Director of Research
Raul E. Perez
President and Managing Director